David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Comcast
CMCSA
|
+$354M |
| 2 |
Wells Fargo
WFC
|
+$274M |
| 3 |
IBM
IBM
|
+$266M |
| 4 |
Qualcomm
QCOM
|
+$257M |
| 5 |
Mondelez International
MDLZ
|
+$224M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$356M |
| 2 |
PayPal
PYPL
|
+$290M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$261M |
| 4 |
NVIDIA
NVDA
|
+$248M |
| 5 |
AABA
Altaba Inc
AABA
|
+$245M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.31% |
| 2 | Healthcare | 10.66% |
| 3 | Consumer Discretionary | 10.29% |
| 4 | Communication Services | 8.78% |
| 5 | Financials | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1226
Angi Inc
ANGI
$200M
| $5.82M | 0.01% |
46,736
-1,883
| -4% | -$230K |
|
|
IVC
1227
DELISTED
Invacare Corporation
IVC
| $5.82M | 0.01% |
369,348
+46,764
| +14% | +$668K |
|
|
SIX
1228
DELISTED
Six Flags Entertainment Corp.
SIX
| $5.82M | 0.01% |
95,445
-164,669
| -63% | -$9.23M |
|
1229
State Street Industrial Select Sector SPDR ETF
XLI
$33.1B
| $5.82M | 0.01% |
+81,900
| New | +$5.63M |
|
|
PACW
1230
DELISTED
PacWest Bancorp
PACW
| $5.81M | 0.01% |
115,046
+23,154
| +25% | +$1.08M |
|
1231
PUT
Intel
INTC
$462B
| $5.81M | 0.01% |
+152,500
| New | +$5.42M |
|
|
OPB
1232
DELISTED
Opus Bank Common Stock
OPB
| $5.8M | 0.01% |
241,703
+19,180
| +9% | +$444K |
|
1233
Nice
NICE
$5.88B
| $5.79M | 0.01% |
71,268
-11,891
| -14% | -$924K |
|
1234
CALL
F5
FFIV
$21.7B
| $5.79M | 0.01% |
48,000
| – | – |
|
|
RTN
1235
PUT
DELISTED
Raytheon Company
RTN
| $5.78M | 0.01% |
31,000
+13,000
| +72% | +$2.29M |
|
1236
Enviri
NVRI
$609M
| $5.77M | 0.01% |
276,020
-252,896
| -48% | -$4.31M |
|
|
DOC
1237
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $5.74M | 0.01% |
323,885
+121,542
| +60% | +$2.24M |
|
|
BCR
1238
PUT
DELISTED
CR Bard Inc.
BCR
| $5.74M | 0.01% |
17,900
| – | – |
|
1239
PUT
Gen Digital
GEN
$17.5B
| $5.73M | 0.01% |
174,700
| – | – |
|
|
WUBA
1240
PUT
DELISTED
58.com Inc
WUBA
| $5.71M | 0.01% |
90,500
-105,800
| -54% | -$6.01M |
|
1241
Bread Financial
BFH
$4.14B
| $5.71M | 0.01% |
32,275
-70,412
| -69% | -$13.1M |
|
|
EBSB
1242
DELISTED
Meridian Bancorp, Inc.
EBSB
| $5.7M | 0.01% |
305,792
+35,111
| +13% | +$614K |
|
1243
Jazz Pharmaceuticals
JAZZ
$16.9B
| $5.7M | 0.01% |
+38,959
| New | +$5.89M |
|
1244
CALL
Thermo Fisher Scientific
TMO
$232B
| $5.7M | 0.01% |
+30,100
| New | +$5.45M |
|
1245
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$23.2B
| $5.67M | 0.01% |
126,000
+84,000
| +200% | +$3.78M |
|
1246
Republic Services
RSG
$67.7B
| $5.67M | 0.01% |
85,889
-1,937
| -2% | -$126K |
|
1247
Campbell Soup
CPB
$7B
| $5.67M | 0.01% |
121,164
-348,279
| -74% | -$17.6M |
|
1248
TriMas Corp
TRS
$1.43B
| $5.66M | 0.01% |
209,777
+7,734
| +4% | +$186K |
|
|
FLY
1249
DELISTED
Fly Leasing Limited
FLY
| $5.66M | 0.01% |
403,820
-32,354
| -7% | -$445K |
|
|
BBBY
1250
DELISTED
Bed Bath & Beyond Inc
BBBY
| $5.65M | 0.01% |
240,721
+86,345
| +56% | +$2.42M |
|
Similar funds
David Shaw's Q3 2017 Portfolio in Review
As of Q3 2017, David Shaw held 3,794 positions worth $65.1B, up 7.7% from $60.5B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.
David Shaw's Q3 2017 filing shows 469 new, 1,367 increased, 1,237 reduced and 370 closed positions. Its largest new stake was Baker Hughes: 3,076,914 shares worth $113M. The largest sale was Gilead Sciences, an estimated $356M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- David Shaw's largest Q3 2017 buy was Baker Hughes: 3,076,914 shares worth $113M.
- David Shaw added most to Comcast in Q3 2017, an estimated $354M increase.
- David Shaw's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $356M.
- David Shaw fully exited Mobileye N.V. in Q3 2017, selling an estimated $72.4M.
- David Shaw's ten largest holdings make up 9.6% of its $65.1B portfolio in Q3 2017.
- David Shaw opened 469 new positions and closed 370 in Q3 2017.
- David Shaw's portfolio value rose 7.7% quarter-over-quarter to $65.1B.
Based on D.E. Shaw & Co's 13F filing for Q3 2017, filed 14 Nov 2017.